Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

REMUS PHARMACEUTICALS LTD.

NSE : REMUSBSE : ISIN CODE : INE0O5T01011Industry : TradingHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( )0 0

NSE1899.3566.85 (+3.65 %)

PREV CLOSE( ) 1832.50

OPEN PRICE ( ) 1900.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1300

TODAY'S LOW / HIGH( ) 1872.00 1900.00

52 WK LOW / HIGH ( )1591.25 2834.75

Select year

Particulars

Mar 2024

Operational & Financial Ratios

Earnings Per Share (Rs)

146.21

CEPS(Rs)

45.61

DPS(Rs)

6.00

Book NAV/Share(Rs)

589.66

Tax Rate(%)

18.38

Margin Ratios

Core EBITDA Margin(%)

13.09

EBIT Margin(%)

15.21

Pre Tax Margin(%)

14.98

PAT Margin (%)

12.22

Cash Profit Margin (%)

12.65

Performance Ratios

ROA(%)

10.13

ROE(%)

29.91

ROCE(%)

32.84

Asset Turnover(x)

0.83

Sales/Fixed Asset(x)

15.76

Working Capital/Sales(x)

3.53

Efficiency Ratios

Fixed Capital/Sales(x)

0.06

Receivable days

196.63

Inventory Days

73.66

Payable days

208.13

Valuation Parameters

PER(x)

11.80

PCE(x)

37.82

Price/Book(x)

11.70

Yield(%)

0.09

EV/Net Sales(x)

4.71

EV/Core EBITDA(x)

30.14

EV/EBIT(x)

30.98

EV/CE(x)

10.17

M Cap / Sales

4.78

Growth Ratio

Net Sales Growth(%)

0.00

Core EBITDA Growth(%)

0.00

EBIT Growth(%)

0.00

PAT Growth(%)

0.00

EPS Growth(%)

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.13

Current Ratio(x)

1.40

Quick Ratio(x)

1.12

Interest Cover(x)

66.71

Total Debt/Mcap(x)

0.01